BioReliance Corporation Appoints James Kramer, Ph.D., Vice President, Global Biologics Operations

ROCKVILLE, Md.--(BUSINESS WIRE)--BioReliance Corporation announced today that James J. Kramer, Ph.D., has been appointed Vice President, Global Biologics Operations, a newly created position. BioReliance Corporation is a leading contract services company that provides biologics safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services to the pharmaceutical and biopharmaceutical industries worldwide.

MORE ON THIS TOPIC